MARKET

NUVB-WS

Nuvation Bio Inc
NUVB-WS
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0024
0.2189
0.0054
-
Analyst Maintains Buy Rating on Taletrectinib Developer, Reaffirming $17 12-Month Price Target on Strengthening ROS1+ NSCLC Outlook
TipRanks · 1d ago
Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers
PR Newswire · 2d ago
Weekly Report: what happened at NUVB last week (0420-0424)?
Weekly Report · 2d ago
Is It Time To Reassess Nuvation Bio (NUVB) After Its Recent Share Price Surge?
Simply Wall St · 6d ago
Analysts Are Bullish on Top Healthcare Stocks: Nuvation Bio (NUVB), Spyre Therapeutics (SYRE)
TipRanks · 04/22 14:00
Nuvation Bio Data And Japan Rights Add Weight To Undervalued Story
Simply Wall St · 04/22 11:20
Nuvation Bio reports results from TRUST-I and TRUST-II trials for IBTROZI
TipRanks · 04/21 22:05
Nuvation Bio Reveals IBTROZI Showed Highly Durable Responses in Longer-Term Follow-Up Data From Pivotal Studies Presented At AACR 2026; IBTROZI Also Demonstrated A High Overall Response Rate In TKI-Naïve Patients At 89.8%; Preclinical Data Presented At AACR Showed Taletrectinib's Potential For Suppressing TrkB-mediated Lung Cancer Cell Migration
Benzinga · 04/21 22:04
More

Webull offers Nuvation Bio Inc stock information, including NYSE: NUVB-WS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVB-WS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUVB-WS stock methods without spending real money on the virtual paper trading platform.